OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG

olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
$1.2684per EA

Strength

5; 25; 40 mg/1; mg/1; mg/1

Manufacturer

Endo USA Inc.

NDC

49884078809

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206137

On Market Since

10/26/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
Increased Diuresis
Thiazide Diuretic
Thiazides

Price History

1W

0.0%

1M

+5.3%

3M

+7.9%

6M

-0.6%

1Y

-17.2%

3Y

-22.2%

5Y

-35.6%

All

-60.8%